Topics

Discontent at Allergan over CEO's chairman role - report

08:01 EDT 1 May 2019 | pharmaphorum

There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports. Reuters reported that Botox maker Allergan defeated a non-binding resolution tabled by hedge fund Appaloosa LP, that woul...

Original Article: Discontent at Allergan over CEO's chairman role - report

NEXT ARTICLE

More From BioPortfolio on "Discontent at Allergan over CEO's chairman role - report"

Quick Search